Bain Set to Face Claims Over Cerevel Trades Before AbbVie Sale

A Delaware judge on Thursday allowed a pension fund to advance claims in a dispute over trades by Bain Capital LP and Perceptive Advisors LLC ahead of Cerevel Therapeutics Holdings Inc.‘s $8.7 billion sale to AbbVie Inc.

The Delaware Chancery Court’s Vice Chancellor J. Travis Laster denied the private equity firms’ motions to dismiss claims exploited inside information to secure a $140 million windfall in those trades in a bench ruling, according to the case docket. Additional details about Laster’s ruling weren’t immediately available.

Bain has argued the private equity firms saw their Cerevel holdings diluted in the ...